We found that low levels of NSE, but not other markers, were a significant predictor of good neurological outcomes, particularly for recovery of general mobility and walking, but not of daily activities and upper limb mobility, which often remains more compromised after a stroke. The gene discussed is ENO2; the disease is stroke disorder.